CELG-RI
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$0.11
+0.00%Leverage
- Debt / equity
- 2.02x
- Net debt / equity
- 1.63x
- Debt / assets
- 0.51x
- Debt / EBITDA
- 2.64x
- Net debt / EBITDA
- 2.13x
Liquidity & coverage
- Current ratio
- 1.53x
- Quick ratio
- 1.38x
- Cash ratio
- 0.59x
- Interest coverage
- 9.21x
- EBITDA / interest
- 9.88x
- Working capital
- $9.9B
Cash & dividend
- FCF / debt
- 0.25x
- Cash flow / debt
- 0.28x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -81.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026